The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-methoxyphenyl)-3-amino-4-(3-(4-methylpiperazin-1-yl)propoxy)benzamide ID: ALA5086350
PubChem CID: 166634903
Max Phase: Preclinical
Molecular Formula: C22H30N4O3
Molecular Weight: 398.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(NC(=O)c2ccc(OCCCN3CCN(C)CC3)c(N)c2)cc1
Standard InChI: InChI=1S/C22H30N4O3/c1-25-11-13-26(14-12-25)10-3-15-29-21-9-4-17(16-20(21)23)22(27)24-18-5-7-19(28-2)8-6-18/h4-9,16H,3,10-15,23H2,1-2H3,(H,24,27)
Standard InChI Key: VQUIONWIVBCEQL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-3.9357 1.6553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9357 0.8303 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.6525 0.4235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3626 0.8378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3600 1.6628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.0701 2.0811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6492 2.0678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2256 0.4161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5088 0.8228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7988 0.4044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0779 0.8152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3645 0.3992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3645 -0.4355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3521 -0.8358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0650 -0.4247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0650 0.4004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3511 0.8143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3461 1.6413 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7831 -0.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7831 -1.6644 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4972 -0.4247 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2130 -0.8359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2130 -1.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9311 -2.0798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6405 -1.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6405 -0.8352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9274 -0.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3563 -2.0811 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0701 -1.6693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
5 7 1 0
1 7 1 0
8 2 1 0
9 8 1 0
10 9 1 0
11 10 1 0
12 11 1 0
12 13 1 0
13 14 2 0
15 14 1 0
15 16 2 0
16 17 1 0
17 12 2 0
17 18 1 0
19 15 1 0
19 20 2 0
21 19 1 0
22 21 1 0
22 23 1 0
24 23 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 22 2 0
25 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 398.51Molecular Weight (Monoisotopic): 398.2318AlogP: 2.55#Rotatable Bonds: 8Polar Surface Area: 80.06Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.10CX LogP: 1.85CX LogD: 1.07Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -1.38
References 1. Liu Y, Li J, Gu Y, Ma L, Cen S, Peng Z, Hu L.. (2022) Synthesis and structure-activity relationship study of new biaryl amide derivatives and their inhibitory effects against hepatitis C virus., 228 [PMID:34883293 ] [10.1016/j.ejmech.2021.114033 ]